Changes in metabolic parameters in ischemic heart disease against the background of metabolic syndrome

Authors

DOI:

https://doi.org/10.15587/2519-4798.2023.285594

Keywords:

ischemic heart disease, metabolic syndrome, diabetes, leptin, glucose, glycated Hb, C-peptide, cholesterol, triacylglycerols, HDL-cholesterol, LDL-cholesterol

Abstract

For many years, and to this day, cardiovascular disease has been and remains the leading cause of death worldwide. Cardiovascular diseases mainly affect people in countries with middle and low living standards.

The aim of the study was to find out the peculiarities of lipid, carbohydrate, and hormonal changes in patients with coronary heart disease against the background of metabolic syndrome.

Materials and methods: 120 patients with verified coronary heart disease were examined, including 60 patients with coronary heart disease without metabolic syndrome and 60 patients with coronary heart disease with metabolic syndrome. The control group consisted of 30 practically healthy individuals of appropriate age and sex. The content of HbA1c, glucositol C-peptide, triacylglycerols, total cholesterol, leptin, HDL-cholesterol, and LDL-cholesterol in blood serum was determined by modern methods.

Results: The analysis of the results of laboratory tests of patients' blood revealed more pronounced changes in carbohydrate and lipid metabolism in patients with coronary artery disease against the background of metabolic syndrome, which indicates the severity of the clinical course in such patients. The results obtained indicate that in coronary heart disease with metabolic syndrome, there are more pronounced dysmetabolic changes: hyperleptinemia, glucosemia, elevated HbA1c, and decreased C-peptide content. Studies have shown that obesity is accompanied by high levels of leptin, which exacerbates insulin resistance and is a trigger for the development of coronary heart disease.

Conclusions: 1. Leptin resistance is a potential cause of insulin resistance and, consequently, obesity, which ultimately leads to metabolic syndrome and the development of coronary heart disease. The data obtained indicate a greater tendency to obesity in women with coronary heart disease complicated by metabolic syndrome.

  1. The data obtained may indicate a latent disorder of carbohydrate metabolism in patients with coronary artery disease without metabolic syndrome.
  2. The detected deviations in lipid metabolism indicate the presence of type II dyslipoproteinemia in patients of group 1 and type IV dyslipoproteinemia in patients of group 2

Author Biographies

Viorika Akimova, Danylo Halytsky Lviv National Medical University

Doctor of Biological Sciences, Professor Department of Clinical Laboratory Diagnostic

Nataliia Demianchuk, Danylo Halytsky Lviv National Medical University

PhD, Assistant

Department of Clinical Laboratory Diagnostic

Mariia Shchurko, Andrey Krupynsky Lviv Medical Academy

PhD, Assistant

Department of Laboratory Medicine

Lyubov Lapovets, Danylo Halytsky Lviv National Medical University

Doctor of Medical Sciences, Professor, Head of Department

Department of Clinical Laboratory Diagnostic

Oleksii Valovyi, Unilab Laboratory

Medical Director

References

  1. Connelly, P. J., Azizi, Z., Alipour, P., Delles, C., Pilote, L., Raparelli, V. (2021). The Importance of Gender to Understand Sex Differences in Cardiovascular Disease. Canadian Journal of Cardiology, 37 (5), 699–710. doi: https://doi.org/10.1016/j.cjca.2021.02.005
  2. DeBoer, M. D., Filipp, S. L., Gurka, M. J. (2020). Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals. Nutrition, Metabolism and Cardiovascular Diseases, 30 (1), 92–98. doi: https://doi.org/10.1016/j.numecd.2019.08.010
  3. Duttaroy, A. K. (2021). Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review. Nutrients, 13 (1), 144. doi: https://doi.org/10.3390/nu13010144
  4. Dzikowicz, D. J., Carey, M. G. (2021). Severity of Myocardial Ischemia Is Related to Career Length Rather Than Age Among Professional Firefighters. Workplace Health & Safety, 69 (4), 168–173. doi: https://doi.org/10.1177/2165079920984080
  5. Bowers, E., Singer, K. (2021). Obesity-induced inflammation: The impact of the hematopoietic stem cell niche. JCI Insight, 6 (3). doi: https://doi.org/10.1172/jci.insight.145295
  6. Bovolini, A., Garcia, J., Andrade, M. A., Duarte, J. A. (2020). Metabolic Syndrome Pathophysiology and Predisposing Factors. International Journal of Sports Medicine, 42 (3), 199–214. doi: https://doi.org/10.1055/a-1263-0898
  7. Carioca, A. A. F., Steluti, J., Carvalho, A. M. de, Silva, A. M., Silva, I. D. C. G. da et al. (2021). Plasma metabolomics are associated with metabolic syndrome: A targeted approach. Nutrition, 83, 111082. doi: https://doi.org/10.1016/j.nut.2020.111082
  8. Lunova, G. (Ed.) (2021). Clinical Biochemistry. Vol. 1. Magnolia, 230–313.
  9. Armitage, P., Berry, G., Matthews, J. N. S. (2008). Statistical methods in medical research. John Wiley & Sons.
  10. Shchurko, M. M., Lapovets, L. Y., Boikiv, N. D. (2022). Diagnostic significance of leptin in patients with ischemic heart disease on the basis of metabolic syndrome. Bulletin of Medical and Biological Research, 1, 110–113.
  11. Atici, A., Asoglu, R., Barman, H. A., Sarikaya, R., Arman, Y., Tukek, T. (2020). Multilayer global longitudinal strain assessment of subclinical myocardial dysfunction related to insulin resistance. The International Journal of Cardiovascular Imaging, 37 (2), 539–546. doi: https://doi.org/10.1007/s10554-020-02037-7
  12. Barber, T. M., Kyrou, I., Randeva, H. S., Weickert, M. O. (2021). Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction. International Journal of Molecular Sciences, 22 (2), 546. doi: https://doi.org/10.3390/ijms22020546

Downloads

Published

2023-05-31

How to Cite

Akimova, V., Demianchuk, N., Shchurko, M., Lapovets, L., & Valovyi, O. (2023). Changes in metabolic parameters in ischemic heart disease against the background of metabolic syndrome. ScienceRise: Medical Science, (3(54), 4–7. https://doi.org/10.15587/2519-4798.2023.285594

Issue

No. 3(54) (2023)

Section

Medical Science

License

Copyright (c) 2023 Viorika Akimova, Nataliia Demianchuk, Mariia Shchurko, Lyubov Lapovets, Oleksii Valovyi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.